Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 4/20 | 0.46 |
| ▸ | FDPS known ✓ | P14324 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28359521 | 0.98 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Lithium Ion SCHEMBL29169465 | 0.98 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL28078856 | 0.98 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Zinc Ion SCHEMBL944727 | 0.98 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL17769221 | 0.98 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| Potassium Ion SCHEMBL988279 | 0.98 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL8846426 | 0.98 | CYP3A4 (0.70) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL11455977 | 0.95 | CYP3A4 (0.66) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL230080 | 0.95 | CYP3A4 (0.66) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL28495667 | 0.92 | CYP3A4 (0.62) | CYP3A4L3MBTL1TSHRTDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117106503-A | Nitrogen-containing carbon quantum dot with ionic structure and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2023-11-24 | — | — | CN | claimed |
| CN-111807373-A | Inorganic nano material with polymer performance and preparation method thereof | 湖南翰墨新材料有限公司 | 2020-10-23 | — | — | CN | claimed |
| US-20100316579-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | GLAXO GROUP LIMITED | 2010-12-16 | — | — | US | claimed |
| EP-2073784-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | Glaxo Group Limited (GB) | 2009-07-01 | — | — | EP | claimed |
| WO-2008049878-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | GLAXO GROUP LIMITED (GB) | 2008-05-02 | — | — | WO | claimed |
| EP-0964736-A1 | RECOVERY AND REUSE OF ANIONIC SURFACTANTS FROM AQUEOUS SOLUTIONS | RHODIA INC. (US) | 1999-12-22 | — | — | EP | claimed |
| US-5843317-A | Recovery and reuse of anionic surfactants from aqueous solutions | RHODIA INC. (US) | 1998-12-01 | — | — | US | claimed |
| WO-1998037951-A1 | RECOVERY AND REUSE OF ANIONIC SURFACTANTS FROM AQUEOUS SOLUTIONS | RHODIA INC. (US) | 1998-09-03 | — | — | WO | claimed |
| US-5378736-A | Epoxidized polylactone, coatings | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-03 | — | — | US | claimed |
| EP-0466596-B1 | Lactone-modified alicyclic composition, and an epoxidized composition thereof | DAICEL CHEM (JP) | 1994-10-05 | — | — | EP | claimed |
| EP-0459913-B1 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEM (JP) | 1994-07-27 | — | — | EP | claimed |
| EP-0466596-A2 | Lactone-modified alicyclic composition, and an epoxidized composition thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1992-01-15 | — | — | EP | claimed |
| EP-0459913-A2 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-12-04 | — | — | EP | claimed |
| CN-117106503-A | Nitrogen-containing carbon quantum dot with ionic structure and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2023-11-24 | — | — | CN | disclosed |
| CN-110511924-B | Isolation of micrornas from biological fluids | 西格马-奥尔德里奇有限责任公司 | 2023-11-03 | — | — | CN | disclosed |
| EP-4223286-A2 | SPRAY DRIED COMPOSITIONS HAVING DIFFERENT DISSOLUTION PROFILES AND PROCESSES FOR THEIR PREPARATION | SpecGx LLC (US) | 2023-08-09 | — | — | EP | disclosed |
| US-5494977-A | A CURABLE EPOXIDIZED POLYESTER, ADDITION POLYMER OR ADDITION-CONDENSATION COPOLYMER FORMED WITH AN ANHYDRIDE STARTING COMPOUND; SOFTENING TEMPERATURE; INKS, COATINGS, VARNISHES | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1996-02-27 | — | — | US | disclosed |
| EP-0540027-A2 | Compositions, expoxidized compositions, a heat-curable resin composition, an epoxy resin composition, radically polymerized composition, a curable resin composition and a polymer having epoxy groups | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1993-05-05 | — | — | EP | disclosed |
| US-4617125-A | Separations by supported liquid membrane cascades | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-10-14 | — | — | US | disclosed |
| US-4472319-A | Preparation of unsaturated nitriles using a surfactant | PHILLIPS PETROLEUM COMPANY (US) | 1984-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316579-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | PHOSPHO1, NAPEPLD, DCPS | CA2 338/4885FDPS 3272/4885CYP3A4 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.